Next Article in Journal
Chalazia Development in Multiple Myeloma: A New Complication Associated with Bortezomib Therapy
Previous Article in Journal
Inflammatory Pseudotumor of the Spleen
 
 
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Differential Diagnosis of Isolated Myeloid Sarcoma: A Case Report and Review of the Literature

1
Division of Hematology/Oncology/Transplantation, Department of Medicine, University of Minneapolis, 1229 Oxford Rd, Deerfield, IL 60015, USA
2
Division of Pathology, University of Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2015, 7(2), 5709; https://doi.org/10.4081/hr.2015.5709
Submission received: 7 November 2014 / Revised: 9 March 2015 / Accepted: 16 April 2015 / Published: 9 June 2015

Abstract

Myeloid sarcoma (MS) is a rare disease entity identified as a variety of manifestations defined by the occurrence of extramedullary myeloid cell masses with or without bone marrow involvement. This case describes an unusual presentation of isolated MS in a 60-year-old otherwise healthy male, who initially presented to his primary care physician with vague abdominal pain. After extensive workup including three omental biopsies, umbilical core biopsy, and inguinal lymph node biopsy, he was ultimately diagnosed with isolated MS with extensive extramedullary tumor burden. Despite advanced extramedullary disease, peripheral cell counts were normal and bilateral bone marrow biopsies unremarkable with normal cellular lineages, morphology, and cytogenetics. The patient underwent induction chemotherapy and is now greater than 100 days post myeloablative unrelated donor marrow transplantation with no evidence of disease recurrence and 100% donor status with full chimerism. This case demonstrates that making a prompt diagnosis with rapid initiation of treatment in myeloid sarcoma can be challenging due to its varied clinical presentation, cytomorphology, cytochemistry, and cytogenetic overlap with other lymphoid malignancies. Once a diagnosis of MS has been made, moving quickly to induction therapy is important. Several studies have shown that improved overall survival is attained when MS is treated as acute myeloid leukemia and increased survival is noted for patients undergoing bone marrow transplantation. Further prospective studies are needed to elucidate the many remaining questions in regards to the natural history, prognosis, and optimal treatment strategies for this deadly disease.
Keywords: myeloid; sarcoma; leukemia myeloid; sarcoma; leukemia

Share and Cite

MDPI and ACS Style

Hagen, P.A.; Singh, C.; Hart, M.; Blaes, A.H. Differential Diagnosis of Isolated Myeloid Sarcoma: A Case Report and Review of the Literature. Hematol. Rep. 2015, 7, 5709. https://doi.org/10.4081/hr.2015.5709

AMA Style

Hagen PA, Singh C, Hart M, Blaes AH. Differential Diagnosis of Isolated Myeloid Sarcoma: A Case Report and Review of the Literature. Hematology Reports. 2015; 7(2):5709. https://doi.org/10.4081/hr.2015.5709

Chicago/Turabian Style

Hagen, Patrick A., Charanjeet Singh, Melissa Hart, and Anne H. Blaes. 2015. "Differential Diagnosis of Isolated Myeloid Sarcoma: A Case Report and Review of the Literature" Hematology Reports 7, no. 2: 5709. https://doi.org/10.4081/hr.2015.5709

Article Metrics

Back to TopTop